Hesson LB - Search Results

1

Epigenetic analysis of childhood acute lymphoblastic leukemia.

Dunwell TL, Hesson LB, Pavlova T, Zabarovska V, Kashuba V, Catchpoole D, Chiaramonte R, Brini AT, Griffiths M, Maher ER, Zabarovsky E, Latif F. Dunwell TL, et al. Among authors: hesson lb. Epigenetics. 2009 Apr 1;4(3):185-93. doi: 10.4161/epi.4.3.8752. Epub 2009 Apr 12. Epigenetics. 2009. PMID: 19430199

2

Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer.

Cooper WN, Dickinson RE, Dallol A, Grigorieva EV, Pavlova TV, Hesson LB, Bieche I, Broggini M, Maher ER, Zabarovsky ER, Clark GJ, Latif F. Cooper WN, et al. Among authors: hesson lb. Oncogene. 2008 Mar 13;27(12):1805-11. doi: 10.1038/sj.onc.1210805. Epub 2007 Sep 24. Oncogene. 2008. PMID: 17891178 Free PMC article.

3

The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias.

Hesson LB, Dunwell TL, Cooper WN, Catchpoole D, Brini AT, Chiaramonte R, Griffiths M, Chalmers AD, Maher ER, Latif F. Hesson LB, et al. Mol Cancer. 2009 Jul 1;8:42. doi: 10.1186/1476-4598-8-42. Mol Cancer. 2009. PMID: 19570220 Free PMC article.

4

A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers.

Dunwell T, Hesson L, Rauch TA, Wang L, Clark RE, Dallol A, Gentle D, Catchpoole D, Maher ER, Pfeifer GP, Latif F. Dunwell T, et al. Mol Cancer. 2010 Feb 25;9:44. doi: 10.1186/1476-4598-9-44. Mol Cancer. 2010. PMID: 20184741 Free PMC article.

5

Analysis of the Birt-Hogg-Dubé (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancer.

da Silva NF, Gentle D, Hesson LB, Morton DG, Latif F, Maher ER. da Silva NF, et al. Among authors: hesson lb. J Med Genet. 2003 Nov;40(11):820-4. doi: 10.1136/jmg.40.11.820. J Med Genet. 2003. PMID: 14627671 Free PMC article.

6

Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma.

Morris MR, Hesson LB, Wagner KJ, Morgan NV, Astuti D, Lees RD, Cooper WN, Lee J, Gentle D, Macdonald F, Kishida T, Grundy R, Yao M, Latif F, Maher ER. Morris MR, et al. Among authors: hesson lb. Oncogene. 2003 Oct 2;22(43):6794-801. doi: 10.1038/sj.onc.1206914. Oncogene. 2003. PMID: 14555992

7

CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations.

Hesson LB, Wilson R, Morton D, Adams C, Walker M, Maher ER, Latif F. Hesson LB, et al. Oncogene. 2005 Jun 2;24(24):3987-94. doi: 10.1038/sj.onc.1208566. Oncogene. 2005. PMID: 15806169

8

The role of RASSF1A methylation in cancer.

Hesson LB, Cooper WN, Latif F. Hesson LB, et al. Dis Markers. 2007;23(1-2):73-87. doi: 10.1155/2007/291538. Dis Markers. 2007. PMID: 17325427 Free PMC article. Review.

9

Epigenetic markers in human gliomas: prospects for therapeutic intervention.

Hesson LB, Krex D, Latif F. Hesson LB, et al. Expert Rev Neurother. 2008 Oct;8(10):1475-96. doi: 10.1586/14737175.8.10.1475. Expert Rev Neurother. 2008. PMID: 18928342 Review.

10

NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers.

Hesson L, Dallol A, Minna JD, Maher ER, Latif F. Hesson L, et al. Oncogene. 2003 Feb 13;22(6):947-54. doi: 10.1038/sj.onc.1206191. Oncogene. 2003. PMID: 12584574

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72 results

Search Page